Great Valley Advisor Group Inc. bought a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 5,219 shares of the company’s stock, valued at approximately $346,000.
A number of other institutional investors have also modified their holdings of the business. Signaturefd LLC grew its position in shares of Ryan Specialty by 12.3% during the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock valued at $89,000 after buying an additional 148 shares during the last quarter. UMB Bank n.a. grew its position in shares of Ryan Specialty by 5.2% during the 3rd quarter. UMB Bank n.a. now owns 5,224 shares of the company’s stock valued at $347,000 after buying an additional 256 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Ryan Specialty by 96.4% during the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after buying an additional 297 shares during the last quarter. Hollencrest Capital Management bought a new stake in shares of Ryan Specialty during the 3rd quarter valued at about $25,000. Finally, CHICAGO TRUST Co NA grew its position in Ryan Specialty by 10.3% in the 3rd quarter. CHICAGO TRUST Co NA now owns 4,838 shares of the company’s stock worth $321,000 after purchasing an additional 450 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have commented on the stock. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $65.00 to $75.00 in a research report on Tuesday, September 24th. Barclays upped their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. JPMorgan Chase & Co. upped their target price on shares of Ryan Specialty from $54.00 to $56.00 and gave the stock an “underweight” rating in a research report on Friday, August 2nd. The Goldman Sachs Group upped their target price on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. Finally, Bank of America upped their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research note on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $71.67.
Ryan Specialty Stock Up 0.0 %
Shares of NYSE:RYAN opened at $75.10 on Thursday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market cap of $19.66 billion, a PE ratio of 97.53, a price-to-earnings-growth ratio of 1.69 and a beta of 0.62. Ryan Specialty Holdings, Inc. has a 52 week low of $41.49 and a 52 week high of $75.86. The firm has a 50 day simple moving average of $69.50 and a 200 day simple moving average of $62.95.
Ryan Specialty (NYSE:RYAN – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, meeting the consensus estimate of $0.41. The business had revenue of $604.69 million during the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm’s quarterly revenue was up 20.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.32 EPS. As a group, research analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current year.
Ryan Specialty Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were given a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.59%. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.
Insider Activity at Ryan Specialty
In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,790 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares in the company, valued at approximately $884,236.54. This represents a 54.42 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director David P. Bolger sold 7,055 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total transaction of $500,058.40. Following the completion of the transaction, the director now owns 78,149 shares in the company, valued at approximately $5,539,201.12. This represents a 8.28 % decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by insiders.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also
- Five stocks we like better than Ryan Specialty
- What is the Shanghai Stock Exchange Composite Index?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- 3 REITs to Buy and Hold for the Long Term
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Calculate Return on Investment (ROI)
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.